NCT04119427

The Safety and Efficacy of Micro-energy Ultrasound in the Treatment of Renal Insufficiency After Renal Transplantation

The Safety and Efficacy of Micro-energy Ultrasound in the Treatment of Renal Insufficiency After Renal Transplantation: A Multicenter, Randomized Clinical Trail

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The safety and efficacy of micro-energy ultrasound in the treatment of renal insufficiency after renal transplantation.

Detailed description

1. Study purposes: To evaluate the safety and efficacy of micro-energy ultrasound in the treatment of renal dysfunction after renal transplantation by measuring serum creatinine, urine volume, urea nitrogen, and transplanted kidney ultrasound, etc. 2. Study design: This is a randomized, double-blind, controlled, multicenter clinical trial. 3. Study objects: Patients with mild to moderate renal insufficiency after renal transplantation. 4. Number of samples: 90 5. Main study center: Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. 6. Treatments: Test group: After installing the disposable treatment head coat, the transplanted kidney was treated with an ultrasonic therapeutic apparatus; after the treatment, the disposable treatment head coat was removed.Patients were treated twice a week for 6 weeks. Control group: The placebo was treated with an ultrasound therapy device and used in the same manner as the test group.

Conditions

• Renal Insufficiency
• Renal Transplantation

Interventions

Type	Name	Description
DEVICE	ultrasonic therapeutic apparatus 1	After installing the disposable treatment head coat, the transplanted kidney was treated with an ultrasonic therapeutic apparatus; after the treatment, the disposable treatment head coat was removed. Patients were treated twice a week for 6 weeks.
DEVICE	ultrasonic therapeutic apparatus 2	The placebo was treated with an ultrasound therapy device and used in the same manner as the test group.

Timeline

• Start date: 2020-05-01
• Primary completion: 2021-12-31
• Completion: 2021-12-31
• First posted: 2019-10-08
• Last updated: 2020-05-12

Locations

1 site across 1 country: China